“RIPTIDE enabled Genotyping is a significant advancement over microarrays. The approach provides a greater density of genomic markers throughout the genome at a significantly reduced cost.”
- Ali Torkamani, Scripps
“With RIPTIDE, our novel analysis pipeline enables unmatched marker density and precision. Hundreds of thousands of informative markers are offered at a breakthrough price”
“With RIPTIDE we were able to discover a statistically significant genetic association to Westie Lung Disease - a canine model for human IPF - that was missed with microarray technology.”
- Matt Huentelman, TGen
Ready to find out more?
Get in touch now.